- CAS
- 1548618-61-6
- Formula
- C23H22N6O6
- MW
- 478.5 g/mol
Pralatrexate
Synonyms: 10-Propargyl-10-deazaaminopterin · N-(4-(1-((2,4-Diamino-6-pteridinyl)methyl)-3-butynyl)benzoyl)-L-glutamic acid · N-{4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}-L-glutamic acid · (2S)-2-({4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}amino)pentanedioic acid
Pralatrexate (CAS 146464-95-1) – Pralatrexate reference standard. C23H23N7O5, MW 477.5. Request a quote: COA, bulk packs and worldwide export.
About Pralatrexate
Pralatrexate (CAS 146464-95-1) is a high-purity reference standard of Pralatrexate offered by Vaqora Chemicals. Its molecular formula is C23H23N7O5 and its molecular weight is 477.5 g/mol. The IUPAC name is (2S)-2-[[4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl]amino]pentanedioic acid. It is also known as 10-Propargyl-10-deazaaminopterin.
It is supplied as a solid. Reference materials should be stored sealed and away from light and moisture, as specified on the accompanying COA. Under GHS it is labelled “Danger”, so handle it with suitable PPE and consult the SDS.
As a reference sample of Pralatrexate, it is used for identification, assay and impurity-profiling work during analytical method development, validation (AMV) and routine QC. Typical end-use sectors are pharmaceutical manufacturing and academic and industrial research.
Available in 10 mg, 25 mg, 50 mg and 100 mg packs, Pralatrexate is dispatched with a Certificate of Analysis (COA) to destinations worldwide.
Typical applications
- Identification & assay
- Method development & validation
- QC reference material
Industries
View every impurity, metabolite and intermediate we list for Pralatrexate.
Pralatrexate impuritiesSpecifications & identifiers
| Product name | Pralatrexate |
|---|---|
| Catalogue No. | VQ-027561 |
| CAS Number | 146464-95-1 |
| IUPAC name | (2S)-2-[[4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl]amino]pentanedioic acid |
| Molecular formula | C23H23N7O5 |
| Molecular weight | 477.5 g/mol |
| Exact mass | 477.1761 |
| Grade | Reference Standard |
| HSN code | 38229090 |
| InChIKey | OGSBUKJUDHAQEA-WMCAAGNKSA-N |
| SMILES | C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O |
| PubChem CID | 148121 |
| Physical form | Solid |
|---|---|
| LogP (XLogP3) | -0.9 |
| H-bond donors / acceptors | 5 / 11 |
| TPSA | 207 Ų |
| Synonyms | 10-Propargyl-10-deazaaminopterin, N-(4-(1-((2,4-Diamino-6-pteridinyl)methyl)-3-butynyl)benzoyl)-L-glutamic acid, N-{4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}-L-glutamic acid, (2S)-2-({4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}amino)pentanedioic acid, L-Glutamic acid, N-(4-(1-((2,4-diamino-6-pteridinyl)methyl)-3-butynyl)benzoyl)-, (2S)-2-((4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzoyl)amino)pentanedioic acid, N-(4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzoyl)-L-glutamic acid, N-(4-(1-((2,4-Diaminopteridin-6-yl)methyl)but-3-yn-1-yl)benzoyl)-L-glutamic Acid, (2S)-2-(4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzamido)pentanedioic acid, L-Glutamic acid, N-[4-[1-[(2,4-diamino-6-pteridinyl)methyl]-3-butyn-1-yl]benzoyl]-, (2S)-2-({4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]phenyl}formamido)pentanedioic acid, (2S)-2-[[4-[1-[(2,4-diaminopteridin-6-yl)methyl]but-3-ynyl]benzoyl]amino]pentanedioic acid |
Safety & hazard information (GHS)
Signal word: Danger
Hazard statements
H301Toxic if swallowedH311Toxic in contact with skinH315Causes skin irritationH319Causes serious eye irritationH331Toxic if inhaledH335May cause respiratory irritationH340May cause genetic defectsH351Suspected of causing cancerH360May damage fertility or the unborn childH372Causes damage to organs through prolonged or repeated exposure
Precautionary statements: P203, P260, P261, P262, P264, P264 + P265, P270, P271, P280, P301 + P316, P302 + P352, P304 + P340, P305 + P351 + P338, P316, P318, P319, P321, P330, P332 + P317, P337 + P317, P361 + P364, P362 + P364, P403 + P233, P405
Classification is indicative (aggregated GHS notifications) and may vary by grade and concentration. Always refer to the SDS supplied with your lot.
Documents
Frequently asked questions
What is the CAS number of Pralatrexate?
The CAS Registry Number of Pralatrexate is 146464-95-1. It is also known as 10-Propargyl-10-deazaaminopterin, N-(4-(1-((2,4-Diamino-6-pteridinyl)methyl)-3-butynyl)benzoyl)-L-glutamic acid, N-{4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}-L-glutamic acid.
What is the molecular formula and molecular weight of Pralatrexate?
Pralatrexate has the molecular formula C23H23N7O5 and a molecular weight of 477.5 g/mol. Its IUPAC name is (2S)-2-[[4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl]amino]pentanedioic acid.
What is Pralatrexate used for?
Pralatrexate is supplied as a characterised reference material related to Pralatrexate. It is used for analytical method development and validation (AMV), impurity profiling, stability studies and quality control, and in ANDA/DMF regulatory filings.
Which grade and pack sizes of Pralatrexate can I order?
We supply Pralatrexate in Reference Standard grade, in 10 mg, 25 mg, 50 mg, 100 mg packs. Larger bulk quantities and custom packing are quoted on request.
Do you provide a COA and SDS with Pralatrexate?
Yes. Every lot of Pralatrexate is shipped with a batch-specific Certificate of Analysis, and a 16-section GHS Safety Data Sheet is provided with the quotation and the shipment.
Can Pralatrexate be shipped internationally?
Yes. Pralatrexate is classified as hazardous, so it is packed in UN-approved packaging and shipped as dangerous goods under IATA/IMDG rules. We export worldwide on EXW, FOB, CIF and DAP terms.
Enquire about Pralatrexate
We reply within one business day with price, pack options, lead time and documentation.
Related products
- CAS
- 146464-93-9
- Formula
- C18H16N6O2
- MW
- 348.4 g/mol
- CAS
- 2058054-07-0
- Formula
- C20H21N7O5
- MW
- 439.4 g/mol